Avenue Therapeutics Inc (NASDAQ:ATXI)

0.709
Delayed Data
As of Sep 29
 +0.038 / +5.66%
Today’s Change
0.54
Today|||52-Week Range
16.65
-38.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$5.5M

Company Description

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.

Contact Information

Avenue Therapeutics, Inc.
1111 Kane Concourse
Bay Harbor Islands Florida 33154
P:(781) 652-4500
Investor Relations:
1781

Employees

Shareholders

Other institutional7.68%
Individual stakeholders17.08%
Mutual fund holders1.22%

Top Executives

Alexandra MacLeanChief Executive Officer & Director
David JinSecretary, Chief Operating & Financial Officer
Scott A. ReinesChief Medical Officer
Michael RyanVP-Clinical Operations & Program Management
Jaclyn JaffeHead-Investor Relations